Skip to main content
OpenTrials
Completed

NCT Number: NCT01558336

Schistosoma Haematobium Infections and Praziquantel

The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.

Completed

Looking for future studies?

Notify Me

Key information

About this study

A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • School children

Exclusion criteria

  • Taking praziquantel

Treatment and study plan

Praziquantel

Drug

praziquantel 40 mg/kg oral tablets

Primary outcomes

  1. cure rate

    Time frame: one year

    The reduction of the prevalence and intensity of S.haematobium infection following a single dose of praziquantel40mg/kg

Secondary outcomes

  1. reduction in the intensity of infection by

    Time frame: one year

    will a single dose of PZQ significantly reduced intensity of infection of S. haematobium infection 1 year after treatment

Sponsors and collaborators

Lead sponsor

University of Khartoum

Other

Collaborators

  • Hikma Pharmaceuticals LLC

Registry information

Official study title

Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel

Important dates

Study start
2008
Primary completion
2012
Study completion
2012
First posted
Mar 20, 2012
Registry last updated
Jan 17, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.